Search research articles
Contact Us
Filters
Showing results (31-40 of 34) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 34 results.
European Journal of Haematology
|
February 1, 1992
High-dose mitoxantrone and etoposide conditioning in autologous bone marrow transplantation for relapsed Hodgkin's disease
S H Lim, T P Baglin, D J Flavell, et al.
Journal of Clinical Pathology
|
September 1, 1989
Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen
W P Stross, R A Warnke, D J Flavell, et al.
British Journal of Cancer
|
February 1, 1994
Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice
B J Morland, J Barley, D Boehm, et al.
British Journal of Cancer
|
December 1, 1995
Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours
D J Flavell, S U Flavell, D A Boehm, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 34) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 34 results.
European Journal of Haematology
|
February 1, 1992
High-dose mitoxantrone and etoposide conditioning in autologous bone marrow transplantation for relapsed Hodgkin's disease
S H Lim, T P Baglin, D J Flavell, et al.
Journal of Clinical Pathology
|
September 1, 1989
Molecule detected in formalin fixed tissue by antibodies MT1, DF-T1, and L60 (Leu-22) corresponds to CD43 antigen
W P Stross, R A Warnke, D J Flavell, et al.
British Journal of Cancer
|
February 1, 1994
Effectiveness of HB2 (anti-CD7)--saporin immunotoxin in an in vivo model of human T-cell leukaemia developed in severe combined immunodeficient mice
B J Morland, J Barley, D Boehm, et al.
British Journal of Cancer
|
December 1, 1995
Preclinical studies with the anti-CD19-saporin immunotoxin BU12-SAPORIN for the treatment of human-B-cell tumours
D J Flavell, S U Flavell, D A Boehm, et al.
Page
of 4